An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Terminated · Phase 3 · NCT03467958
Conditions: Crohn Disease
At a glance
- Research payments reported, 2025
- $343,690
- U.S. investigators named
- 25
- Sites paid
- 24
- Planned or actual enrollment
- 854
About the trial
- Sponsor
- Celgene
- Tested
- Ozanimod (drug)
- Dates
- Started 2018-08-24; completion 2024-10-31
- Results posted
- Yes
This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease.
From ClinicalTrials.gov, last updated 2025-09-17. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Celgene Corporation reported $343,690 in research payments for this study in 2025 (25 payments).
Products named: Zeposia
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Amit Bhanvadia, M.D. Gastroenterology · Anaheim, CA
- Hyun S. Kim, MD Gastroenterology · San Diego, CA
- Eric Mao, M.D. Gastroenterology · Sacramento, CA
- Jatinder S. Pruthi, M.D. Gastroenterology · Lancaster, CA
- Deborah D. Proctor, MD Gastroenterology · New Haven, CT
- Salam F. Zakko, MD Gastroenterology · Bristol, CT
- Ammar Hemaidan, MD Gastroenterology · Port Orange, FL
- Heba N. Iskandar, M.D. Gastroenterology · Atlanta, GA
- David B. Rausher, M.D. Specialist · Decatur, GA
- Douglas C. Wolf, MD Gastroenterology · Atlanta, GA
- Paul M. Hendrix, M.D. Gastroenterology · Idaho Falls, ID
- Jessica R. Allegretti, M.D. Gastroenterology · Boston, MA
- Kenolisa C. Onwueme, M.D., PH.D. Gastroenterology · Baltimore, MD
- Parakkal Deepak, MD Gastroenterology · Saint Louis, MO
- Nilesh I. Lodhia, MD Gastroenterology · Charlotte, NC
- Michael J. Digiovanna, D.O. Internal Medicine · North Massapequa, NY
- Randy S. Longman, MD / PHD Gastroenterology · New York, NY
- Keith Sultan, MD Gastroenterology · Manhasset, NY
- Arun Swaminath, M.D. Gastroenterology · New York, NY
- Jeffrey E. Chasteen, DO Family Medicine · Tulsa, OK
- Lisa A. Mueller, MD Gastroenterology · Providence, RI
- Erin M. Forster, M.D. Gastroenterology · Charleston, SC
- Dilawar Ajani, M.D. Internal Medicine · Houston, TX
- Jessica B. Johnson, MD Gastroenterology · Salt Lake City, UT
- Larry E. Clark JR., M.D. Gastroenterology · Lynchburg, VA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Gastroenterology Associates of Central Virginia $90,510
- Medical University of South Carolina $57,613
- Weill Medical College of Cornell University $51,965
- Aga, Llc $17,103
- Sct Research Llc $14,600
- Grand Teton Research Group $14,457
- Biomedical Research Alliance of New York, Llc $12,722
- Medical Associates Research Group, Inc $12,500
- Metro Comprehensive Physical and Aquatic Therapy $9,500
- Advanced Medical Research Center $8,715
- University of Utah Hospital and Clinics, UT $7,448
- Washington University $6,204
- Texas Digestive Disease Consultants Southlake $6,000
- University of California Davis Medical Center, CA $5,512
- Essential Medical Research, Llc $5,500
- Clinnova Research Solutions $5,000
- Atlanta Center for Gastroenterology, PC $3,750
- Topography Health Inc $3,300
- Lee Daeyeol Mms $2,600
- Connecticut Clinical Research Institute Llc $2,500
- Brigham and Womens Physicians Organization $2,000
- Om Research Llc $2,000
- Emory University Hospital, GA $1,690
- Carolinas Medical Center-Northeast, NC $500
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.